GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 227 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2019. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $243,000 | -90.9% | 5,000 | -90.2% | 0.02% | -90.9% |
| Q2 2019 | $2,683,000 | -20.7% | 51,000 | -20.2% | 0.16% | -21.9% |
| Q1 2019 | $3,382,000 | +50.0% | 63,900 | +16.4% | 0.21% | +38.2% |
| Q4 2018 | $2,254,000 | +80.3% | 54,900 | +66.9% | 0.15% | +108.2% |
| Q3 2018 | $1,250,000 | -34.5% | 32,900 | -55.8% | 0.07% | -36.0% |
| Q2 2018 | $1,909,000 | -18.7% | 74,500 | -1.3% | 0.11% | -24.0% |
| Q1 2018 | $2,349,000 | -17.9% | 75,500 | +3.9% | 0.15% | -16.7% |
| Q4 2017 | $2,861,000 | +101.6% | 72,700 | +59.1% | 0.18% | +63.6% |
| Q3 2017 | $1,419,000 | +13.5% | 45,700 | 0.0% | 0.11% | +8.9% |
| Q2 2017 | $1,250,000 | – | 45,700 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 460,000 | $14,872,000 | 13.19% |
| VHCP Management II, LLC | 141,611 | $4,578,000 | 3.76% |
| Perceptive Advisors | 1,186,630 | $38,363,000 | 2.84% |
| RTW INVESTMENTS, LP | 175,156 | $5,663,000 | 1.87% |
| Casdin Capital, LLC | 65,000 | $2,101,000 | 1.86% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,163,811 | $37,626,000 | 1.52% |
| RA Capital Management | 457,142 | $14,779,000 | 1.46% |
| VHCP Management, LLC | 60,691 | $1,962,000 | 1.19% |
| Iguana Healthcare Management, LLC | 110,000 | $3,556,000 | 1.17% |
| Partner Investment Management, L.P. | 15,634 | $505,000 | 0.83% |